Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Standard

Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease. / Specht, L.; Geisler, C.; Hansen, M.M.; Skakkebaek, N.E.

I: Scand.J Haematol., Bind 33, Nr. 4, 1984, s. 356-362.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Harvard

Specht, L, Geisler, C, Hansen, MM & Skakkebaek, NE 1984, 'Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease', Scand.J Haematol., bind 33, nr. 4, s. 356-362.

APA

Specht, L., Geisler, C., Hansen, M. M., & Skakkebaek, N. E. (1984). Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease. Scand.J Haematol., 33(4), 356-362.

Vancouver

Specht L, Geisler C, Hansen MM, Skakkebaek NE. Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease. Scand.J Haematol. 1984;33(4):356-362.

Author

Specht, L. ; Geisler, C. ; Hansen, M.M. ; Skakkebaek, N.E. / Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease. I: Scand.J Haematol. 1984 ; Bind 33, Nr. 4. s. 356-362.

Bibtex

@article{704365004e1c11df928f000ea68e967b,
title = "Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease",
abstract = "16 young men in long-term remission after standard treatment for the early stages of Hodgkin's disease were examined for testicular function 48 to 125 months after termination of therapy. The patients had received mantle field irradiation, plus either irradiation of infradiaphragmatic lymph nodes (7 patients) or 6 cycles of MOPP (9 patients). 5 patients had almost normal semen quality judged by seminal fluid analysis. 11 patients had reduced semen quality (8 severely reduced) and often elevated FSH values. Semen samples of poor quality were significantly more common in patients treated with MOPP (7/9) than in those treated with infradiaphragmatic irradiation (1/7). One patient showed signs of regeneration of spermatogenesis. None had experienced reduction in libido and sexual performance after therapy; correspondingly, none had below normal testosterone values or elevated LH values. Patients should be informed about the risk of infertility before treatment. If in a given case several treatment options with equal prospective antineoplastic effect are weighed against one another, the patient's possible desire to retain fertility should favour the use of radiotherapy as opposed to chemotherapy, especially including alkylating agents Udgivelsesdato: 1984/10",
author = "L. Specht and C. Geisler and M.M. Hansen and N.E. Skakkebaek",
note = "UI - 85065635LA - engPT - Journal ArticleDA - 19850118IS - 0036-553XSB - IMCY - DENMARK",
year = "1984",
language = "Dansk",
volume = "33",
pages = "356--362",
journal = "Scandinavian Journal of Haematology",
issn = "0036-553X",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease

AU - Specht, L.

AU - Geisler, C.

AU - Hansen, M.M.

AU - Skakkebaek, N.E.

N1 - UI - 85065635LA - engPT - Journal ArticleDA - 19850118IS - 0036-553XSB - IMCY - DENMARK

PY - 1984

Y1 - 1984

N2 - 16 young men in long-term remission after standard treatment for the early stages of Hodgkin's disease were examined for testicular function 48 to 125 months after termination of therapy. The patients had received mantle field irradiation, plus either irradiation of infradiaphragmatic lymph nodes (7 patients) or 6 cycles of MOPP (9 patients). 5 patients had almost normal semen quality judged by seminal fluid analysis. 11 patients had reduced semen quality (8 severely reduced) and often elevated FSH values. Semen samples of poor quality were significantly more common in patients treated with MOPP (7/9) than in those treated with infradiaphragmatic irradiation (1/7). One patient showed signs of regeneration of spermatogenesis. None had experienced reduction in libido and sexual performance after therapy; correspondingly, none had below normal testosterone values or elevated LH values. Patients should be informed about the risk of infertility before treatment. If in a given case several treatment options with equal prospective antineoplastic effect are weighed against one another, the patient's possible desire to retain fertility should favour the use of radiotherapy as opposed to chemotherapy, especially including alkylating agents Udgivelsesdato: 1984/10

AB - 16 young men in long-term remission after standard treatment for the early stages of Hodgkin's disease were examined for testicular function 48 to 125 months after termination of therapy. The patients had received mantle field irradiation, plus either irradiation of infradiaphragmatic lymph nodes (7 patients) or 6 cycles of MOPP (9 patients). 5 patients had almost normal semen quality judged by seminal fluid analysis. 11 patients had reduced semen quality (8 severely reduced) and often elevated FSH values. Semen samples of poor quality were significantly more common in patients treated with MOPP (7/9) than in those treated with infradiaphragmatic irradiation (1/7). One patient showed signs of regeneration of spermatogenesis. None had experienced reduction in libido and sexual performance after therapy; correspondingly, none had below normal testosterone values or elevated LH values. Patients should be informed about the risk of infertility before treatment. If in a given case several treatment options with equal prospective antineoplastic effect are weighed against one another, the patient's possible desire to retain fertility should favour the use of radiotherapy as opposed to chemotherapy, especially including alkylating agents Udgivelsesdato: 1984/10

M3 - Tidsskriftartikel

VL - 33

SP - 356

EP - 362

JO - Scandinavian Journal of Haematology

JF - Scandinavian Journal of Haematology

SN - 0036-553X

IS - 4

ER -

ID: 19398964